These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 9737646

  • 1. Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment.
    Farnier M.
    Am J Cardiol; 1998 Aug 27; 82(4B):47J-51J. PubMed ID: 9737646
    [Abstract] [Full Text] [Related]

  • 2. Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety.
    Stein E.
    Am J Cardiol; 1998 Aug 27; 82(4B):40J-46J. PubMed ID: 9737645
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies.
    Hunninghake DB.
    Am J Cardiol; 1998 Aug 27; 82(4B):26J-31J. PubMed ID: 9737643
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia.
    Mabuchi H, Koizumi J, Kajinami K.
    Am J Cardiol; 1998 Aug 27; 82(4B):52J-55J. PubMed ID: 9737647
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
    Insull W, Isaacsohn J, Kwiterovich P, Ra P, Brazg R, Dujovne C, Shan M, Shugrue-Crowley E, Ripa S, Tota R.
    J Int Med Res; 2000 Aug 27; 28(2):47-68. PubMed ID: 10898118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1,030 hypercholesterolemic patients. The Cerivastatin Study Group.
    Dujovne CA, Knopp R, Kwiterovich P, Hunninghake D, McBride TA, Poland M.
    Mayo Clin Proc; 2000 Nov 27; 75(11):1124-32. PubMed ID: 11075741
    [Abstract] [Full Text] [Related]

  • 11. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores EA, González-Valdez H, Gómez Pérez FJ.
    Metabolism; 2001 Jun 27; 50(6):729-33. PubMed ID: 11398153
    [Abstract] [Full Text] [Related]

  • 12. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.
    Zambón D, Ros E, Rodriguez-Villar C, Laguna JC, Vázquez M, Sanllehy C, Casals E, Sol JM, Hernández G.
    Metabolism; 1999 Jan 27; 48(1):47-54. PubMed ID: 9920144
    [Abstract] [Full Text] [Related]

  • 13. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD, Balagtas CC, Rowan JP, Black DM.
    Atherosclerosis; 1996 Nov 15; 127(1):113-22. PubMed ID: 9006811
    [Abstract] [Full Text] [Related]

  • 14. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL, Farnier M, Macdonell G, Perevozskaya I, Davies MJ, Gumbiner B, Musliner TA.
    Metabolism; 2008 Jun 15; 57(6):796-801. PubMed ID: 18502262
    [Abstract] [Full Text] [Related]

  • 15. Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study.
    Insua A, Massari F, Rodríguez Moncalvo JJ, Rubén Zanchetta J, Insua AM.
    Endocr Pract; 2002 Jun 15; 8(2):96-101. PubMed ID: 11942772
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of cerivastatin and pravastatin in the treatment of primary hypercholesterolemia.
    Saunders E, Ferdinand K, Yellen LG, Tonkon MJ, Krug-Gourley S, Poland M.
    J Natl Med Assoc; 2000 Jul 15; 92(7):319-26. PubMed ID: 10946527
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia.
    Yu WC, Chen CH, Tsao HM, Ding YA.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun 15; 65(6):260-7. PubMed ID: 12201566
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia.
    Isaacsohn J, Insull W, Stein E, Kwiterovich P, Patrick MA, Brazg R, Dujovne CA, Shan M, Shugrue-Crowley E, Ripa S, Tota R, Cerivastatin Study Group.
    Clin Cardiol; 2001 Sep 15; 24(9 Suppl):IV1-9. PubMed ID: 11594407
    [Abstract] [Full Text] [Related]

  • 19. Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.
    Sweany AE, Shapiro DR, Tate AC, Goldberg RB, Stein EA.
    Clin Ther; 1995 Sep 15; 17(2):186-203. PubMed ID: 7614520
    [Abstract] [Full Text] [Related]

  • 20. International multicentre comparison of cerivastatin with placebo and simvastatin for the treatment of patients with primary hypercholesterolaemia. International Cerivastatin Study Group.
    Betteridge DJ.
    Int J Clin Pract; 1999 Jun 15; 53(4):243-50. PubMed ID: 10563066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.